Senior Clinical Research Director

Sanofi•Cambridge, MA

7d•$236,250 - $393,750•Hybrid

About The Position

The Senior Clinical Research Director (sCRD), Rare Disease, is a senior scientific and clinical leader responsible for shaping and executing clinical development strategy for assigned rare disease programs — driving them from early development through registration with a patient-centric focus. The sCRD serves as a recognized scientific authority within the Rare Disease TA, championing clinical excellence, challenging conventional approaches, and advancing Sanofi's mission to deliver transformative therapies to underserved patients. Join the engine of Sanofi’s mission — where deep immunoscience meets bold, AI-powered research. In R&D, you’ll drive breakthroughs that could turn the impossible into possible for millions. We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives.

Requirements

MD or equivalent required
5+ years in drug development, or 5+ years pharmaceutical/biotech industry experience in clinical development.
Rare Disease: Demonstrated experience with orphan drug frameworks and small patient population trial design.
Technical Skills: Expertise in clinical pharmacology, biomarker strategy, benefit-risk assessment, and innovative trial designs.
Leadership: Proven ability to lead cross-functional global teams without direct authority; strong negotiation and decision-making skills.
Communication: Exceptional written and verbal English; ability to present to scientific, regulatory, executive, and patient audiences.

Nice To Haves

MD/PhD strongly preferred
Board certification in metabolic medicine, medical genetics, nephrology, or cardiology.
Direct experience with lysosomal storage disorders, enzyme replacement therapy, or gene therapy.
Prior experience as medical spokesperson in FDA/EMA meetings.
Familiarity with real-world evidence (RWE) in rare disease regulatory submissions.
Peer-reviewed publication record in the relevant therapeutic area.
Experience with business development and scientific due diligence.

Responsibilities

Lead design and authorship of study synopses, CDPs, and clinical sections of IDPs.
Oversee end-to-end trial execution through cross-functional units, ensuring GCP and regulatory compliance.
Define and manage timelines, budgets, and risk mitigation strategies with Clinical Operations, Project Management, and Procurement.
Serve as strategic clinical lead and medical spokesperson within the Global Project Team, Protocol Review Committee and Executive Leadership.
Contribute to biomarker identification and provide due diligence support for business development opportunities.
Maintain deep expertise in internal medicine, metabolic diseases, nephrology and rare disease biology.
Integrate preclinical data, clinical pharmacology, and competitive intelligence to inform strategy.
Champion innovative trial designs — adaptive, natural history, and real-world evidence — appropriate for rare disease contexts.
Influence product value proposition through evidence-based input on unmet needs and development approaches.
Lead programs at key regulatory interactions (FDA, EMA, PMDA) as primary medical spokesperson.
Develop engagement strategies for pre-IND, End-of-Phase meetings, and Advisory Committee preparations.
Support label development, registration submissions, and post-approval modifications.
Ensure all activities comply with FDA, EMA, CHMP, ICH guidance and Sanofi policies.
Drive timely publication of clinical data in peer-reviewed journals and at scientific congresses.
Lead advisory board meetings and maintain strategic relationships with KOLs, patient advocacy organizations, and rare disease consortia.
Align cross-functional stakeholders around a unified development vision; present CDPs to governance and senior leadership.
Partner with Medical Affairs, Biostatistics, Translational Medicine, Regulatory, Market Access, and Commercial functions.
Mentor Clinical Research Directors and Clinical Scientists and contribute to talent development within the Rare Disease TA.